Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 90d62bd979a7173b-LAX IP: 101.37.83.79 UTC time: 2025-02-05T22:00:05+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4